Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation

Antonietta Picascia, Vincenzo Grimaldi, Rossella Paolillo, Maria Vasco, Amelia Casamassimi, Francesco Paolo De Luca, Francesco Cavalca, Concetta Schiano, Claudio Napoli

Research output: Contribution to journalArticle

Abstract

Objective: Intravenous immunoglobulin (IVIG) products are known to have beneficial immunomodulatory effects on several inflammatory and autoimmune disorders. These effects could be attributed to a different inhibitory action on complement factors, but other mechanisms could be implicated, e.g., immunocomplexes development and/or anti-idiotypic antibodies. Positive results on the reduction of anti-Human Leukocyte Antigens (HLA) antibodies in highly sensitized patients have also been found. The present study focuses on the effect of IVIG on the reduction of Panel Reactive Antibody level and crossmatch positivity in sensitized patients awaiting kidney transplantation. Methods: The study was performed adapting an in vitro assay on sensitized patients' sera in waiting list for kidney transplantation. Sera of twelve highly sensitized patients were evaluated for the cytotoxicity inhibition after 10% IVIG treatment. Results: A reduction of anti- HLA antibody levels was observed in 75% (9/12) of treated patients in vitro, while 25% (3/12) resulted unresponsiveness. Particularly, our data showed a significantly higher Panel Reactive Antibody reduction for T lymphocytes (p

Original languageEnglish
Pages (from-to)585-588
Number of pages4
JournalRenal Failure
Volume36
Issue number4
DOIs
Publication statusPublished - 2014

Keywords

  • Desensitization of patient sera
  • Intravenous immunoglobulin
  • Kidney transplantation
  • Panel reactive antibody
  • Sensitized patients

ASJC Scopus subject areas

  • Nephrology
  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Intravenous human immunoglobulin treatment of serum from HLA-sensitized patients in kidney transplantation'. Together they form a unique fingerprint.

  • Cite this